This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Essential cookies enable basic functions and are necessary for the website to function properly.
Statistics cookies collect information anonymously. This information helps us to understand how our visitors use our website.
Marketing cookies are used by third parties or publishers to display personalized advertisements. They do this by tracking visitors across websites.

Radiopharmaceuticals & Medical Radioisotopes

A New Generation of Targeted Diagnostic and Therapeutic Radiopharmaceuticals & Radioisotopes

We offer radioisotopes for clinical applications as well as research purposes. We have therefore established a GMP manufacturing of a first-in-class radioisotopes and -generator platform for the development of a new generation of targeted cancer diagnostics and therapies.

In 2016, we received Marketing Authorization for EndolucinBeta®. EndolucinBeta® respectively no-carrier-added (n.c.a.) lutetium (177Lu) chloride is a radiopharmaceutical precursor and indicated for the radiolabeling of disease-specific carrier molecules. The emerging radiopharmaceutical can be applied in Targeted Radionuclide Therapy for cancer treatment.

Get in touch with our Sales Team

If you are in need of any further information regarding radioisotopes or radiopharmaceuticals and our worldwide service, please contact us:


Radioisotopes: RadioisotopeOperations(at)
Radiopharmaceuticals: RadiopharmaOperations(at)

Phone: +49 89 329 8986 6000